University of Michigan

The University of Michigan manages a significant endowment, making it a major institutional investor. Its Investment Office, established in 1999, oversees the Long Term Portfolio with the goal of supporting the university's mission through student scholarships, research, and academic programs. The university acts as both a Limited Partner (LP) by investing in external funds (including venture capital, private equity, and real estate) and as a direct investor. Direct investments in startups, particularly those spun out of university research, are handled by entities like Innovation Partnerships. This arm manages several venture funds, including the Accelerate Blue Fund, the Michigan Biomedical Venture Fund, and the Michigan Invests in New Technology Startups (MINTS) program, which participated in the FlexDex Surgical investment.